Key result
Low lymphocyte-to-monocyte ratio linked to ~8-fold higher mortality in STEMI patients undergoing primary PCI.
Why the study?
The relationship between lymphocyte-to-monocyte ratio 48 hours after admission and mortality in STEMI patients treated with primary PCI was investigated.
Does a low lymphocyte-to-monocyte ratio (LMR) 48 hours after admission predict 30-day and long-term mortality in patients with STEMI undergoing primary PCI?
Cohort (n=318)
Does a low lymphocyte-to-monocyte ratio (LMR) 48 hours after admission predict 30-day and long-term mortality in patients with STEMI undergoing primary PCI?
Answers are grounded in this paper and cite their sources.
A low lymphocyte-to-monocyte ratio at 48 hours post-admission is an independent prognostic marker for increased 30-day and long-term mortality in STEMI patients treated with primary PCI.
We investigated whether the lymphocyte-to-monocyte ratio (LMR) 48 hours after admission is related to 30-day and long-term mortality in patients with ST-elevation myocardial infarction (STEMI) who were treated with primary percutaneous coronary intervention (PCI). We evaluated 318 consecutive patients with STEMI who were undergoing primary PCI. The relationship between the LMR 48h and all-cause mortality (30-day and long-term) was analyzed by categorizing the patients into tertiles (T) according to LMR 48h —T1 (>2.46), T2 (1.67-2.46), and T3 (<1.67). The T3 group exhibited the highest risk of 30-day all-cause mortality (hazard ratio [HR]: 8.093 [1.006-65.074]; P = .049). For long-term mortality, a significantly higher mortality risk was observed in both T2 (HR: 2.005 [1.021-3.939]; P = .043) and T3 groups (HR: 2.374 [1.160-4.857]; P < .001) compared to the T1 group (reference group). In multivariate analysis, these associations remained unaltered even after adjusting for confounders. A low LMR at 48 hours after admission may be independently associated with both 30-day and long-term mortality in patients with STEMI who were treated with primary PCI. This marker may be used for identifying patients with STEMI at high risk.
No takes yet. Share an insight, caveat, or question.
Kırış et al. (2017) conducted a cohort in ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) (n=318). Low lymphocyte-to-monocyte ratio (Tertile 3: <1.67) at 48 hours vs. High lymphocyte-to-monocyte ratio (Tertile 1: >2.46) was evaluated on 30-day all-cause mortality (HR 8.093, 95% CI 1.006-65.074, p=.049). A low lymphocyte-to-monocyte ratio at 48 hours was associated with increased 30-day all-cause mortality in STEMI patients undergoing primary PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: